๐ Key Information Summary
- Fatigue is the most prevalent symptom in palliative care, affecting 70โ100% of patients with advanced disease and profoundly impairing quality of life.
- Functional decline signals disease progression and influences prognosis, care planning, and the shift from curative to comfort-focused goals.
- Systematic assessment must distinguish potentially reversible causes (anaemia, hypothyroidism, depression, medication side effects, infection, dehydration) from irreversible disease-related fatigue.
- Validated tools include the Edmonton Symptom Assessment System (ESAS), the Brief Fatigue Inventory (BFI), and the Palliative Care Outcome Scale (POS) โ use serially to track trends.
- Performance status scoring (PPS or ECOG) quantifies functional capacity and guides treatment intensity, referral, and funding eligibility (e.g., PAC, NDIS).
- Energy conservation โ pacing, prioritising, delegating, and planning rest โ is the cornerstone non-pharmacological strategy.
- Rehabilitation in palliative care (palliative rehabilitation) aims to maximise remaining function and independence, not to restore premorbid capacity.
- Dexamethasone (low dose, short course) and methylphenidate (cautious, off-label) have the strongest evidence for pharmacological fatigue management; psychostimulants require cardiac monitoring.
- Equipment and assistive aids (mobility aids, bathroom modifications, hospital beds, pressure-care devices) preserve independence and reduce carer burden.
- Aboriginal and Torres Strait Islander patients experience higher rates of functional limitation and face barriers to equipment access and rehabilitation services in remote communities.
- Goals-of-care conversations should be integrated early โ fatigue and functional decline are triggers for advance care planning (ACP) discussions.
- A multidisciplinary approach โ physiotherapy, occupational therapy, palliative care, psychology, social work, and primary care โ is essential for holistic management.
Introduction & Australian Epidemiology
Fatigue and functional decline are among the most distressing and pervasive symptoms experienced by patients with advanced, life-limiting illness. Fatigue โ defined as a subjective sense of overwhelming, sustained exhaustion that is not proportional to recent activity and interferes with usual functioning โ is reported by 70โ100% of patients receiving palliative care across cancer, organ failure, and neurological diagnoses. Functional decline, characterised by progressive loss of independence in activities of daily living (ADLs) and mobility, often accompanies or follows fatigue and is a strong predictor of prognosis, care needs, and caregiver burden.
In Australia, the AIHW estimates that over 150,000 people access palliative care services annually, with the majority experiencing fatigue as a significant limiting symptom. The National Palliative Care Strategy (2018) identifies symptom management and maintaining quality of life as core goals. The burden of fatigue is particularly high in patients with advanced cancer (prevalence 60โ90%), chronic obstructive pulmonary disease (COPD, 50โ70%), heart failure (60โ80%), end-stage kidney disease (ESKD, 60โ90%), and motor neurone disease (MND, 80โ100%).
Functional decline drives transitions in care โ from community to residential aged care, from self-management to formal support packages (e.g., Commonwealth Home Support Programme, Home Care Packages, NDIS for younger Australians). Understanding the trajectory and optimising management is essential for person-centred palliative care.
Fatigue is multifactorial: Always assess for reversible contributors (anaemia, thyroid dysfunction, depression, medications, infection, dehydration) before attributing fatigue solely to the underlying disease. Treating reversible causes can meaningfully improve quality of life even in advanced illness.
Assessment
A structured, holistic assessment of fatigue and functional decline is the foundation of effective management. This must encompass the patient's subjective experience, objective functional measures, and the broader psychosocial and spiritual context.
Subjective Fatigue Assessment
Patient self-report remains the gold standard. Validated tools enable serial monitoring and communication between team members:
| Tool | Description | Scoring | Use in Practice |
|---|---|---|---|
| Edmonton Symptom Assessment System (ESAS-r) | 9-item symptom scale including fatigue, rated 0โ10 | 0 = best, 10 = worst | Widely used in Australian palliative care services; quick bedside tool |
| Brief Fatigue Inventory (BFI) | 9-item questionnaire assessing fatigue severity and interference with daily activities | Mild <4, moderate 4โ6, severe 7โ10 | Well validated in cancer-related fatigue; recommended by MASCC/ASCO |
| Palliative Care Outcome Scale (POS) | 12-item multidimensional tool covering physical, psychological, and spiritual needs | Higher score = greater burden | Used in Australian palliative care research and clinical audit |
| Functional Assessment of Chronic Illness Therapy โ Fatigue (FACIT-F) | 13-item fatigue subscale; part of the FACIT measurement system | 0โ52; higher = less fatigue | Validated across cancer and chronic disease; useful for research |
| Numerical Rating Scale (NRS) | Single-item 0โ10 scale | 0 = none, 10 = worst imaginable | Quick screening in resource-limited settings |
Functional Status Assessment
Objective functional measures complement patient self-report and are critical for prognostication, service eligibility, and equipment prescription:
| Scale | Description | Application |
|---|---|---|
| Palliative Performance Scale (PPSv2) | 11-level scale (0โ100%) assessing ambulation, activity, self-care, intake, and consciousness | Prognostication; PPS โค50% associated with median survival weeks; guides PAC eligibility |
| ECOG Performance Status (PS) | 5-level scale (0โ4) from fully active to completely disabled | Standard in oncology; determines chemotherapy suitability and clinical trial eligibility |
| Katz Index of ADLs | 6 basic ADLs: bathing, dressing, toileting, transferring, continence, feeding | Determines care level; guides Home Care Package level allocation |
| Barthel Index | 10-item scale (0โ100) of basic ADLs | Widely used in rehab and aged care settings; tracks change over time |
| Timed Up and Go (TUG) | Time to stand, walk 3 m, turn, walk back, sit | >12 seconds indicates increased falls risk; practical physiotherapy assessment |
Investigations for Reversible Causes
A targeted panel of investigations should be performed when fatigue is disproportionate to disease stage or when a treatable contributor is suspected. Avoid over-investigation in the terminal phase.
Essential
Full blood examination (FBE)
Detects anaemia, infection, haematological malignancy progression. MBS Item 65070.
Essential
Serum biochemistry (U&E, LFTs, calcium, glucose)
Identifies renal impairment, hepatic dysfunction, hypercalcaemia, hypoglycaemia. MBS Item 66500.
Essential
Thyroid function tests (TSH, fT4)
Excludes hypothyroidism/hyperthyroidism as reversible cause. MBS Item 66720.
Available
C-reactive protein (CRP)
Assesses inflammatory burden; correlates with cancer-related fatigue severity. MBS Item 66352.
Available
Vitamin B12 and folate
Deficiency common in elderly and malnourished; easily corrected. MBS Item 66816.
Available
Iron studies (ferritin, transferrin saturation)
Iron deficiency, even without anaemia, contributes to fatigue. MBS Item 66090.
Available
Cortisol (morning or short Synacthen test)
Consider if adrenal insufficiency suspected (prior corticosteroid use, pituitary disease). MBS Item 66651.
Specialist
Sleep study (polysomnography)
If obstructive sleep apnoea or significant sleep disturbance suspected. Requires respiratory/sleep medicine referral.
Practical tip: In the last weeks of life (PPS โค30%), investigations are usually not indicated unless results would directly change management and the patient is willing to undergo the associated interventions. Focus on comfort.
Medication Review
Polypharmacy is a common and underrecognised contributor to fatigue. A structured medication review should identify and deprescribe agents with sedating or fatigue-promoting side effects:
- Opioids: Sedation, cognitive clouding โ consider dose reduction, opioid rotation, or switching to a less sedating agent
- Benzodiazepines and sedative-hypnotics: Drowsiness, psychomotor slowing โ gradual taper if feasible
- Anticholinergics: (e.g., oxybutynin, promethazine, tricyclic antidepressants) โ cognitive and physical fatigue
- Beta-blockers: Exercise intolerance, lethargy โ review indication and dose
- Antihistamines (1st generation): Sedation โ switch to non-sedating alternatives
- Anticonvulsants: (e.g., pregabalin, gabapentin, levetiracetam) โ dose-dependent sedation
- Corticosteroids: Myopathy with prolonged use; steroid-induced hyperglycaemia โ review ongoing indications
Energy Conservation
Energy conservation is a self-management strategy that teaches patients to use their limited energy reserves purposefully and efficiently. It is the most widely recommended non-pharmacological intervention for fatigue in palliative care and chronic disease. The aim is not to eliminate fatigue but to enable patients to participate in activities that are most meaningful to them.
The Four Principles of Energy Conservation
1
Prioritise
Identify the activities most important to the patient's quality of life and identity. Delegate, defer, or eliminate lower-priority tasks. Use the patient's own values โ not the clinician's assumptions โ to set priorities.
2
Plan
Schedule high-energy activities for times of day when the patient feels most alert (typically mid-morning). Spread demanding tasks across different days. Allow time for preparation (e.g., sitting to shower, pre-organising items).
3
Pace
Alternate activity with rest. Break tasks into smaller steps with rest breaks between. Stop before exhaustion โ the "80% rule" (cease activity at 80% of perceived energy capacity to prevent post-exertional malaise).
4
Position
Use body positioning to reduce energy expenditure. Sit rather than stand for tasks (e.g., seated showering, seated meal preparation). Use supportive seating and adaptive equipment. Good posture reduces muscular effort.
Practical Strategies by Activity
| Activity | Energy Conservation Strategy |
|---|---|
| Bathing / showering | Use shower stool/chair; hand-held shower rose; warm (not hot) water; towel off while seated; consider bed bath on low-energy days |
| Dressing | Sit to dress; choose loose-fitting clothes with front closures; use long-handled shoe horn and sock aid; dress lower body in bed if needed |
| Meal preparation | Use lightweight utensils and cookware; prepare meals while seated; use pre-prepared or frozen meals; Meals on Wheels (available across all Australian states/territories) |
| Household tasks | Delegate cleaning and laundry to family, volunteers, or Home Care Package services; use lightweight cleaning tools; reduce frequency of non-essential tasks |
| Shopping / errands | Online shopping (Woolworths, Coles, IGA delivery); use mobility aids for short outings; consolidate errands into one trip |
| Socialising | Plan visits for high-energy times; keep visits short (15โ30 minutes); use phone/video calls on low-energy days; accept help with hosting |
| Exercise / movement | Gentle, regular movement within tolerance (walking, seated exercises); avoid prolonged bed rest; consult physiotherapy for individualised programme |
Role of Occupational Therapy
Occupational therapists (OTs) are central to energy conservation education. They can conduct home assessments, recommend and prescribe equipment, train patients in energy-saving techniques, and facilitate access to community services. In Australia, OT services are funded through Medicare (Chronic Disease Management plans โ MBS Item 10958, up to 5 allied health sessions per calendar year), Home Care Packages, NDIS (for patients <65 years), and state-funded community palliative care programs.
Key message: Energy conservation is most effective when introduced early โ ideally at the time of diagnosis of a life-limiting illness โ and reinforced regularly by the multidisciplinary team. It empowers patients to maintain agency over their daily lives.
Rehabilitation
Palliative rehabilitation (also termed "rehabilitative palliative care") integrates rehabilitation principles into palliative care to maximise function, independence, and quality of life. Unlike traditional rehabilitation aimed at restoring premorbid function, palliative rehabilitation accepts the progressive nature of the underlying disease and focuses on achievable, person-centred goals within the patient's current capacity and prognosis.
Principles of Palliative Rehabilitation
- Person-centred goals: Goals are set collaboratively with the patient and family โ e.g., "attend my granddaughter's wedding," "walk to the letterbox," "transfer independently to the toilet"
- Realistic and adaptive: Goals are modified as function changes; success is measured by the patient's satisfaction, not by normative benchmarks
- Interdisciplinary: Physiotherapy, occupational therapy, speech pathology, exercise physiology, psychology, and social work all contribute
- Continuous: Rehabilitation is not a discrete episode but an ongoing process integrated into daily care
- Prevents deconditioning: Even minimal activity preserves muscle mass, cardiovascular fitness, and psychological wellbeing
Exercise Prescription
Exercise is the single most effective non-pharmacological intervention for cancer-related fatigue (Level I evidence) and has demonstrated benefits in COPD, heart failure, and chronic kidney disease. Prescription must be individualised to the patient's current functional level, disease trajectory, and preferences.
| Functional Level (PPS) | Exercise Approach | Examples |
|---|---|---|
| 70โ100% (ambulant, minimal limitations) | Moderate-intensity aerobic + resistance exercise; structured programme | Walking 20โ30 min, 3โ5ร/week; resistance bands; group exercise classes; community gym (with clearance) |
| 50โ60% (limited activity, needs assistance) | Low-intensity, shorter bouts; seated and supported exercises | Seated marching, ankle weights, gentle walking 10โ15 min, balance exercises, chair yoga |
| 30โ40% (mainly bed/chair bound) | Passive and assisted range of motion; bed-based exercises | Assisted limb movements, ankle pumps, gentle stretching, repositioning, tilt-table if available |
| 10โ20% (totally bed bound) | Passive range of motion; comfort positioning; sensory stimulation | Gentle passive movements, massage, music, repositioning for comfort |
Pharmacological Management of Fatigue
When non-pharmacological strategies are insufficient, pharmacological options may be considered. Evidence is modest and primarily from cancer-related fatigue studies. Always weigh benefits against potential adverse effects in the palliative population.
Dexamethasone
Various generics ยท Corticosteroid
Adult dose
4โ8 mg PO/IV mane for 1โ2 weeks, then taper or cease
Paediatric dose
0.1โ0.3 mg/kg/day (max 8 mg); specialist guidance
Route
Oral (preferred) or IV
Duration
Short course (1โ2 weeks); review response; avoid prolonged use
Renal adjustment
None required
Hepatic adjustment
None required
Key precautions
Hyperglycaemia (monitor BGL in diabetics), insomnia, myopathy, GI irritation; administer in morning to reduce sleep disruption
PBS status
โ PBS General Benefit
Methylphenidate
Ritalinยฎ ยท Concertaยฎ ยท Psychostimulant
Adult dose
5 mg PO mane, titrate to 10โ20 mg mane ยฑ 5 mg at midday (max 30 mg/day)
Paediatric dose
Not routinely used for fatigue in paediatric palliative care; specialist only
Route
Oral
Duration
Trial for 1โ2 weeks; continue if effective
Renal adjustment
None required
Hepatic adjustment
Use with caution; dose reduction may be needed
Key precautions
Tachycardia, hypertension, anxiety, insomnia, appetite suppression; ECG before commencing if cardiac history; avoid in severe cardiovascular disease
PBS status
โ ๏ธ Authority Required (for ADHD indication โ off-label for fatigue)
Modafinil
Modavigilยฎ ยท Provigilยฎ ยท Wakefulness-promoting agent
Adult dose
100 mg PO mane, titrate to 200 mg mane (max 400 mg/day)
Paediatric dose
Not established for fatigue indication
Route
Oral
Duration
Trial for 2โ4 weeks; reassess
Renal adjustment
None required
Hepatic adjustment
Reduce dose by 50% in hepatic impairment
Key precautions
Headache, nausea, anxiety, insomnia; Stevens-Johnson syndrome (rare); evidence weaker than methylphenidate
PBS status
โ ๏ธ Authority Required (narcolepsy indication โ off-label for fatigue)
Psychostimulant caution: Methylphenidate and modafinil are used off-label for palliative care fatigue. Evidence is limited (small RCTs, heterogeneous populations). Always obtain baseline cardiovascular assessment, discuss realistic expectations with patient and family, and review after 1โ2 weeks. Do not use in the terminal phase.
Psychological and Complementary Approaches
- Cognitive behavioural therapy (CBT): Strongest evidence among psychological interventions for fatigue; addresses unhelpful beliefs, sleep hygiene, and activity scheduling. Available via clinical psychologists (MBS Items 80000โ80015 under GP Mental Health Treatment Plan)
- Mindfulness-based stress reduction (MBSR): Emerging evidence for fatigue reduction; group programs available through some Australian palliative care services and cancer councils
- Sleep hygiene interventions: Regular sleepโwake schedule, limit daytime naps to <30 minutes, avoid stimulants in the evening, dark quiet bedroom, treat underlying sleep disorders
- Music therapy: Evidence for reducing fatigue perception and improving mood; offered by registered music therapists in many Australian palliative care services
- Acupuncture: Some evidence for cancer-related fatigue; available through the Australian Acupuncture and Chinese Medicine Association (AACMA) practitioners
Managing Fatigue in Specific Disease Groups
| Condition | Disease-Specific Considerations |
|---|---|
| Advanced cancer | Tumour burden, treatment side effects, cancer cachexia syndrome, anaemia (consider EPO/transfusion), corticosteroids as anti-tumour and anti-fatigue treatment |
| Heart failure (NYHA IIIโIV) | Cardiac rehabilitation principles apply; fluid and sodium restriction; optimise diuretics; avoid overdiuresis causing pre-renal failure; cardiac cachexia |
| COPD (GOLD Stage IV) | Pulmonary rehabilitation has strongest evidence; oxygen therapy if hypoxic; manage hyperinflation; address anxiety-driven breathlessness-fatigue cycle |
| End-stage kidney disease | Consider EPO (epoetin alfa โ PBS Authority Required) for renal anaemia; correct iron deficiency; manage uraemic symptoms; dialysis fatigue is common |
| Motor neurone disease (MND) | Progressive and irreversible; focus on assistive technology, communication devices (AAC), respiratory support (BiPAP); MND Australia support services |
| Multiple sclerosis | Fatigue affects 75โ95% of MS patients; amantadine (PBS Authority Required) has modest benefit; cooling strategies; energy conservation is first-line |
Equipment & Aids
Assistive equipment and home modifications are essential to support functional independence, reduce falls risk, and ease the burden on caregivers. In Australia, a range of funding pathways exist to support equipment provision for palliative care patients. Timely provision is critical โ delays can result in unnecessary hospital admissions, carer breakdown, and loss of the patient's preferred place of care.
Common Equipment Categories
| Category | Equipment Examples | Purpose | Prescribing Clinician |
|---|---|---|---|
| Mobility aids | Walking stick (single/quad), wheeled walker (4-wheel walker/rollator), wheelchair (manual/transit), mobility scooter | Maintain safe ambulation; conserve energy; community access | OT, physiotherapist, GP |
| Bathroom / toileting | Shower chair/stool, over-toilet frame, commode (mobile/fixed), raised toilet seat, grab rails | Safe bathing and toileting; reduce falls; enable seated self-care | OT (primary prescriber) |
| Bedroom | Hospital-grade electric profiling bed, pressure-relieving mattress (alternating air/foam), bed lever, over-bed table, bed rail (half/full) | Safe transfers, pressure injury prevention, comfort, carer ergonomics | OT, nurse, palliative care team |
| Pressure care | Static foam mattress (Grade 1โ2), alternating pressure mattress (Grade 3โ4), pressure-relieving cushion (ROHOยฎ, Jayยฎ), heel elevation devices | Prevention and management of pressure injuries in immobile patients | Wound nurse specialist, OT, palliative care team |
| Seating | Riser-recliner armchair, supportive wheelchair cushion, tilt-in-space wheelchair, perching stool | Prolonged comfortable sitting; safe sit-to-stand transfers; kitchen task support | OT, physiotherapist |
| Daily living aids | Long-handled reacher, dressing aids (sock aid, button hook), lightweight kitchen utensils, jar openers, tap turners, non-slip mats | Maximise independence in self-care tasks with minimal energy expenditure | OT |
| Respiratory support | Portable suction unit, nebuliser, oxygen concentrator/cylinders (if hypoxic), bilevel positive airway pressure (BiPAP) machine | Manage dyspnoea and secretion burden; reduce fatigue from respiratory effort | Respiratory physician, palliative care physician |
| Communication aids | Augmentative and alternative communication (AAC) devices, speech-generating devices, writing aids, call bells/pendant alarms | Maintain communication as speech declines (MND, stroke, advanced dementia); emergency signalling | Speech pathologist, OT |
| Home modifications | Ramp installation, handrails, grab rails, doorway widening, accessible bathroom renovation, stair lift | Enable safe home environment; prevent institutionalisation | OT (assessment and recommendation); builder (installation) |
Australian Funding Pathways for Equipment
| Funding Pathway | Eligibility | Equipment Covered |
|---|---|---|
| State-based Equipment Programs (e.g., VIC: SWEP; NSW: ENABLE; QLD: Medical Aids Subsidy Scheme โ MASS; SA: Equipment Program; WA: Independent Living Centre) | Permanent disability or chronic condition; Australian resident; assessed by approved prescriber (usually OT) | Mobility aids, bathroom equipment, beds, mattresses, seating, communication aids, home modifications |
| NDIS (National Disability Insurance Scheme) | Permanent disability; under 65 years at time of access request; Australian citizen/permanent resident | Assistive technology, home modifications, personal care supports, capacity building |
| Commonwealth Home Support Programme (CHSP) / Home Care Packages (HCP) | 65+ years (or 50+ for ATSI); assessed via My Aged Care (1800 200 422) | Minor equipment, home modifications, personal care, allied health |
| Palliative Care (PAC) funding / State palliative care services | Diagnosis of life-limiting illness; palliative care team involvement; varies by state/territory | Hospital beds, mattresses, syringe drivers, oxygen, specialised palliative care equipment |
| DVA (Department of Veterans' Affairs) | Gold Card / White Card holders | Broad range of aids and equipment; home modifications; community nursing |
| Charitable organisations | Variable criteria; often based on financial need | Red Cross (equipment loans), Rotary, Lions, local palliative care volunteer services |
Timeliness matters: Equipment for palliative care patients should be prioritised. Many state programs have expedited pathways for palliative care โ e.g., SWEP (Victoria) offers a "palliative care fast-track" for urgent equipment needs. Always indicate palliative status on the prescription form and contact the program directly if urgency is not reflected in standard processing times.
Falls Prevention
Falls are a major cause of morbidity and hospitalisation in palliative care patients with fatigue and functional decline. A comprehensive falls prevention strategy includes:
- Home hazard assessment (OT recommended): remove trip hazards, improve lighting, secure rugs, install grab rails
- Appropriate footwear: well-fitting, non-slip, low-heeled shoes โ avoid walking in socks
- Medication review: reduce sedating medications, address postural hypotension (review antihypertensives, opioids)
- Strength and balance exercises (physiotherapy-guided)
- Vision and hearing assessment where appropriate
- Personal alarm / pendant (e.g., through St John Ambulance, VitalCALL, or state-based programs) for patients living alone
Special Populations
Pregnancy
Fatigue in pregnancy
Physiological fatigue is common, especially in the first and third trimesters. If pathological fatigue is suspected (e.g., anaemia, thyroid dysfunction, gestational diabetes), investigate and treat accordingly.
Medication considerations
Methylphenidate and modafinil are Category B3 (avoid in pregnancy). Dexamethasone โ use only if benefits outweigh risks; corticosteroids may affect fetal growth with prolonged use. Non-pharmacological strategies are first-line.
Exercise
Moderate exercise is safe and beneficial in most pregnancies. Pelvic floor exercises, walking, swimming, and prenatal yoga can reduce fatigue. Refer to physiotherapy with obstetric experience.
Paediatrics
Assessment challenges
Young children cannot self-report fatigue reliably. Use parent/carer proxy reports and observational tools. The PedsQL Multidimensional Fatigue Scale is validated for ages 2โ18 years. School attendance and play participation are practical functional markers.
Common causes
In paediatric palliative care (cancer, neuromuscular disease, metabolic disease), fatigue is driven by the disease process, treatment (chemotherapy, radiation), pain, poor sleep, and psychological distress. Iron deficiency and thyroid dysfunction should be excluded.
Management
Play-based activity and age-appropriate exercise (physiotherapy). School reintegration plans with occupational therapy support. NDIS (for children with permanent disability) can fund assistive technology and therapy. Dexamethasone may be used cautiously for symptom control in oncology contexts. Psychostimulants are generally avoided.
School & social participation
Liaison with school regarding energy limitations and modified curriculum. Starlight Foundation, Camp Quality, and Redkite provide psychosocial support and activities for children with serious illness.
Elderly
Frailty and fatigue
Frailty syndrome overlaps significantly with fatigue. Assess using the Clinical Frailty Scale (CFS) or FRAIL questionnaire. Frailty and fatigue together accelerate functional decline and increase mortality risk.
Multimorbidity
Multiple comorbidities contribute synergistically to fatigue. Polypharmacy is the norm โ medication review (including deprescribing) is a high-yield intervention. Use the STOPP/START criteria as a guide.
Cognitive factors
Delirium and dementia amplify perceived fatigue and limit rehabilitation potential. Screen with the 4AT or MMSE. Treat reversible cognitive contributors (infection, medications, constipation, dehydration).
Aged care access
My Aged Care (1800 200 422) for assessment and support. Home Care Packages (Levels 1โ4) can fund allied health, equipment, and personal care. Residential aged care may be necessary when home-based support is insufficient.
Renal Impairment
Uraemic fatigue
Fatigue in ESKD is multifactorial: uraemia, renal anaemia, dialysis burden, mineral bone disease, depression. It is one of the top three symptoms reported by dialysis patients and a common reason for considering withdrawal from dialysis.
Erythropoiesis-stimulating agents (ESAs)
Epoetin alfa or darbepoetin alfa (PBS Authority Required) for renal anaemia with target Hb 100โ115 g/L. Ensure adequate iron stores first (ferritin >200 ยตg/L, transferrin saturation >20%).
Medication considerations
Most fatigue medications (dexamethasone, methylphenidate, modafinil) do not require renal dose adjustment. However, metabolite accumulation of other co-prescribed medications (opioids, gabapentinoids) may worsen fatigue โ review and adjust.
Hepatic Impairment
Fatigue in liver disease
Fatigue is present in 60โ80% of patients with chronic liver disease, particularly primary biliary cholangitis and advanced cirrhosis. Mechanisms include altered serotonergic neurotransmission, autonomic dysfunction, and muscle wasting (sarcopenia).
Medication adjustments
Modafinil โ reduce dose by 50% in hepatic impairment. Methylphenidate โ use cautiously. Avoid prolonged corticosteroid use if possible (risk of hepatotoxicity with some agents; dexamethasone generally safer than prednisolone in this context). Review all hepatically metabolised medications.
Nutrition
Malnutrition and sarcopenia are highly prevalent; dietitian involvement is essential. Small frequent meals, late-evening snack (to prevent overnight catabolism), and adequate protein intake (1.2โ1.5 g/kg/day unless encephalopathic).
Immunocompromised
Infection-related fatigue
Subclinical and overt infections (e.g., CMV, EBV reactivation, fungal infections, chronic UTIs) are common contributors to fatigue in immunosuppressed patients. Low threshold for investigation (FBE, CRP, blood cultures, urine MCS).
Corticosteroid caution
In patients already on immunosuppressive regimens (e.g., post-transplant, autoimmune disease), additional corticosteroids for fatigue carry increased infection risk. Weigh benefits carefully. Address underlying immunosuppression-related fatigue causes first.
Exercise safety
Exercise is generally safe and beneficial even in immunocompromised patients, but avoid crowded gyms/public pools during periods of severe neutropenia. Home-based or supervised exercise programmes are preferred.
Aboriginal and Torres Strait Islander Health Considerations
Aboriginal and Torres Strait Islander Health
Aboriginal and Torres Strait Islander Australians experience a disproportionate burden of chronic disease, disability, and functional limitation. The 2018โ19 National Aboriginal and Torres Strait Islander Health Survey found that 46% of Indigenous Australians reported at least one disability or long-term health condition, with higher rates of severe or profound core activity limitation compared with non-Indigenous Australians. Fatigue and functional decline intersect with systemic inequities in healthcare access, housing, and social determinants of health.
Key Considerations
Recommended actions: Partner with local ACCHOs and AHW/AHPs for culturally safe assessment and management. Use the RHDAustralia End-of-Life Care Pathway for Aboriginal and Torres Strait Islander peoples. Prioritise equipment supply through palliative care fast-track pathways. Explore telehealth rehabilitation and OT consultations for remote communities. Involve family in all goal-setting conversations. Apply for Closing the Gap PBS Co-Payment Measure for PBS medicines (reduced co-payment for eligible Indigenous patients).
Goals of Care & Advance Care Planning
Fatigue and functional decline are pivotal triggers for goals-of-care conversations and advance care planning (ACP). As function deteriorates, the patient's capacity to participate in future medical decision-making may decline. Early, sensitive conversations ensure that care remains aligned with the patient's values and preferences.
When to Initiate ACP
- Progressive decline in PPS or ECOG score (particularly PPS dropping below 50%)
- Increasing dependence on others for ADLs
- Recurrent hospitalisations or presentations to the emergency department
- Patient or family raising questions about prognosis, future care, or "what happens ifโฆ"
- Transition points: diagnosis of incurable illness, cessation of active treatment, referral to palliative care, transition to residential aged care
Key Documents in Australia
| Document | Purpose | Legal Status |
|---|---|---|
| Advance Care Directive (ACD) | Patient's documented preferences for future medical treatment, including refusal of specific interventions | Legally binding in all Australian states/territories (specific legislation varies โ e.g., Medical Treatment Planning and Decisions Act 2016 in VIC) |
| Substitute Decision-Maker (SDM) | Appointed person to make medical decisions if the patient loses capacity | Legally recognised; hierarchy defined by state/territory legislation |
| Resuscitation Plan / Not-for-Resuscitation (NFR) Order | Documents the decision regarding CPR in the event of cardiac/respiratory arrest | Medical order; should be documented in consultation with patient/SDM |
| Goals of Care (GOC) plan | Broader treatment plan describing the overall intent (curative, palliative, comfort) and specific management preferences | Clinical document; shared across care settings |
Resources: Advance Care Planning Australia (advancecareplanning.org.au) provides state-specific templates, training modules, and a national registry. MyValues (myvalues.com.au) allows patients to document their values online. End-of-Life Law for Clinicians (endoflifelaw.education) provides legal guidance by jurisdiction.
๐ References
- 1. Radbruch L, Strasser F, Elsner F, et al. Fatigue in palliative care patients โ an EAPC approach. Palliative Medicine. 2008;22(1):13โ32.
- 2. Bower JE, Bak K, Berger A, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol. 2014;32(17):1840โ1850.
- 3. Mรผcke M, Mochamat M, Cuhls H, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2015;(5):CD006788.
- 4. NHS England. End of Life Care โ Energy Conservation for Fatigue. NHS Improvement; 2019.
- 5. Australian Institute of Health and Welfare (AIHW). Palliative care services in Australia. AIHW; 2023. Cat. No. HWV 79.
- 6. Palliative Care Australia. National Palliative Care Strategy 2018. Canberra: Commonwealth of Australia; 2018.
- 7. Oldenmenger WH, Sillevis Smitt PA, van Dooren S, et al. A systematic review on the efficacy of pharmacological interventions for cancer-related fatigue. Support Care Cancer. 2019;27(11):4051โ4062.
- 8. Australian Commission on Safety and Quality in Health Care (ACSQHC). National Safety and Quality Health Service Standards. 2nd ed. Sydney: ACSQHC; 2021.
- 9. Rehabilitation and palliative care: a position statement. Australasian Journal on Ageing. 2020;39(3):e289โe295.
- 10. Australian Institute of Health and Welfare (AIHW). Aboriginal and Torres Strait Islander Health Performance Framework: Summary report 2023. AIHW; 2023.
- 11. RHDAustralia (Remote and Rural Health). Caring for Aboriginal and Torres Strait Islander People at End of Life: A Guide for Health Professionals. Darwin: RHDAustralia; 2020.
- 12. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733โ742.
- 13. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6โ9.
- 14. National Institute for Health and Care Excellence (NICE). Cancer-related fatigue: prevalence, screening and management. NICE Clinical Guideline CG177; 2022.
- 15. Advance Care Planning Australia. Advance Care Planning: A National Framework. Austin Health; 2023. Available at: advancecareplanning.org.au.